https://www.selleckchem.com/pr....oducts/fti-277-hcl.h
CONCLUSIONS Shikonin could be a promising candidate for paclitaxel-resistant NSCLC treatment.BACKGROUND Glioma has the characteristics of high incidence and mortality, and is a common malignant tumor of the central nervous system. Circular RNAs (circRNAs) have been reported to play vital roles in progression of cancer including glioma, and circKIF4A is up-regulated in glioma tissues. However, its role and mechanisms in gliomas are unclear. METHODS circKIF4A and miR-139-3p were determined by qRT-PCR. Transwell assay, wound-healing as